CA
NZ
UK
AU
IND
US
Enovis Corporation (NYSE:ENOV) fell 2.43% to $19.71 in today's intraday trading. The medical technology company focused on orthopedics was formed when the former Colfax separated its medical business, and it has since pursued acquisitions to build scale in higher-growth reconstructive markets.
bioAffinity Technologies (NASDAQ:BIAF) shares jumped sharply in pre-market trading after the company announced it is advancing the potential application of its noninvasive lung test for surveillance of lung cancer patients following curative-intent treatment. The expanded use case targets a large and growing population of …
CollPlant Biotechnologies (NASDAQ:CLGN) penny stock declined in pre-market trading after the company confirmed that its previously approved one-for-ten reverse share split will take effect when theNasdaqCapital Market opens on September 4, 2026. Every ten existing shares will convert into one share, with fractional shares …
Olema Pharmaceuticals (NASDAQ:OLMA) shares edged higher in pre-market trading after the company disclosed the terms of an inducement equity award granted to Jason V. O'Byrne, who joined as Chief Financial Officer in mid-August. The options carry an exercise price matching the stock's closing price …
Phreesia (NYSE:PHR) shares declined in pre-market trading after the company's fiscal second-quarter results showed adjusted earnings per share falling significantly short ofWall Streetexpectations, even as revenue grew double digits and came in ahead of estimates. The mismatch between top-line strength and bottom-line disappointment drove …
Summit Therapeutics (NASDAQ:SMMT) shares rose in pre-market trading after the company noted that its partner, Akeso Inc., announced positive overall survival results from the Phase 3 HARMONi-2 study. The trial, conducted entirely in China and sponsored by Akeso, evaluated ivonescimab as a monotherapy against …
A clinical-stage biopharmaceutical company saw its stock crater in pre-market trading after announcing that a late-stage study of its lead therapy for a rare, inherited neurodevelopmental disorder did not achieve statistical significance on its primary endpoint, a measure of cognitive improvement, nor on a …
AIM ImmunoTech (NYSE American:AIM) penny stock rose in pre-market trading after the company announced expanded patent protection across 18 European countries and the United Kingdom for its drug Ampligen in treating Long COVID, the persistent post-viral symptoms some patients experience following COVID-19 infection. The …
Spun off from Medtronic plc in March 2026, MiniMed Group is a global medical technology company developing an integrated portfolio of diabetes management solutions, including automated insulin delivery systems, insulin pumps, continuous glucose monitors, and the CareLink software platform. Headquartered in Northridge, California, and …
Headquartered in New Brunswick, New Jersey, and founded in 1887, Johnson & Johnson operates through two core segments, Innovative Medicine and MedTech. The Innovative Medicine segment focuses on therapies spanning immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolic disease, and pulmonary hypertension, anchored by …
Please wait processing your request...